Carbamic acid,N-heptyl-,(4aS,9aS)-2,3,4,4a,9,9a-hexahydro-2,4a,9-trimethyl-1,2-oxazino[6,5-b]indol-6-ylester, hydrochloride (1:1) (147606-23-3)

Identification
Name:	Carbamic acid,N-heptyl-,(4aS,9aS)-2,3,4,4a,9,9a-hexahydro-2,4a,9-trimethyl-1,2-oxazino[6,5-b]indol-6-ylester, hydrochloride (1:1)
Synonyms:	Carbamicacid, heptyl-,(4aS,9aS)-2,3,4,4a,9,9a-hexahydro-2,4a,9-trimethyl-1,2-oxazino[6,5-b]indol-6-ylester, monohydrochloride (9CI); Carbamic acid, heptyl-,2,3,4,4a,9,9a-hexahydro-2,4a,9-trimethyl-1,2-oxazino[6,5-b]indol-6-yl ester,monohydrochloride, (4aS-cis)-; 1,2-Oxazino[6,5-b]indole, carbamic acid deriv.;CHF 2060
CAS:	147606-23-3
Molecular Formula:	C21H33 N3 O3 . Cl H
Molecular Structure:
Properties
Safety Data

Other Product

Carbamic acid,N-(2-methylphenyl)-,(4aS,9aS)-2,3,4,4a,9,9a-hexahydro-2,4a,9-trimethyl-1,2-oxazino[6,5-b]indol-6-ylester, hydrochloride (1:1)
Carbamic acid,N-(3-methylphenyl)-,(4aS,9aS)-2,3,4,4a,9,9a-hexahydro-2,4a,9-trimethyl-1,2-oxazino[6,5-b]indol-6-ylester, hydrochloride (1:1)
Carbamic acid, heptyl-,(4aS,9aS)-2,3,4,4a,9,9a-hexahydro-2,4a,9-trimethyl-1,2-oxazino[6,5-b]indol-6-ylester (9CI)
N-(2-Ethylphenyl)carbamic acid (4aS,9aS)-2,4a,9-trimethyl-2,3,4,4a,9,9a-hexahydro[1,2]oxazino[6,5-b]indol-6-yl ester hydrochloride
1,2-Oxazino[6,5-b]indole,7-bromo-2,3,4,4a,9,9a-hexahydro-2-methyl-4a,9-bis(3-methyl-2-buten-1-yl)-,(4aS,9aS)-
1,2-Oxazino[6,5-b]indol-6-ol,2,3,4,4a,9,9a-hexahydro-2,4a,9-trimethyl-, (4aS,9aS)-
1,2-Oxazino[6,5-b]indol-6-ol,2,3,4,4a,9,9a-hexahydro-2,4a,9-trimethyl-, 6-(N-methylcarbamate), (4aS,9aS)-
L-Glutamic acid, hydrochloride, mixt. with (4aS-cis)-2,3,4,4a,9,9a-hexahydro-2,4a,9-trimethyl-1,2-oxazino(6,5-b)indol-6-yl methylcarbamate mono(2-hydroxybenzoate) and papain
1H-Pyrano[3,4-d]oxepin-4-carboxylicacid,9-[2-(3,4-dihydroxyphenyl)ethoxy]-4a,5,6,8,9,9a-hexahydro-1-hydroxy-6-oxo-,2-(3,4-dihydroxyphenyl)ethyl ester, (1R,4aS,9S,9aS)-
1H-Pyrano[3,4-d]oxepin-4-carboxylicacid, 4a,5,6,8,9,9a-hexahydro-1-hydroxy-9-[2-(4-hydroxyphenyl)ethoxy]-6-oxo-,methyl ester, (1R,4aS,9S,9aS)-rel-(+)-
2-Propenoic acid,3-phenyl-,(2aR,4S,4aS,5R,6R,8S,9aS,10S,10aR,10bS)-4,10,10b-tris(acetyloxy)-5-(benzoyloxy)-2a,3,4,4a,5,6,8,9,9a,10,10a,10b-dodecahydro-6-hydroxy-9a-(1-hydroxy-1-methylethyl)-4a,7-dimethyl-1H-azuleno[5',6':3,4]benz[1,2-b]oxet-8-ylester, (2E)-
2-Propenoic acid,3-phenyl-,(2aR,4S,4aS,5R,6R,8S,9aS,10S,10aR,10bS)-4,5,10,10b-tetrakis(acetyloxy)-6-(benzoyloxy)-2a,3,4,4a,5,6,8,9,9a,10,10a,10b-dodecahydro-9a-(1-hydroxy-1-methylethyl)-4a,7-dimethyl-1H-azuleno[5',6':3,4]benz[1,2-b]oxet-8-ylester, (2E)- (9CI)
Dodecanoic acid,(1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-1,1a,1b,4,4a,5,7a,7b,8,9-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-9-(2-methyl-1-oxobutoxy)-5-oxo-9aH-cyclopropa[3,4]benz[1,2-e]azulen-9a-ylester
2-Propenoic acid,3-(methylthio)-,(3R,3aR,4S,- 4aS,5R,6S,8aR,9aR)-decahydro-4-methoxy-3,- 4a,5-trimethyl-1-oxo-3a,9a-epoxynaphtho[2,- 3-b]furan-6-yl ester,(2Z)-
salicylic acid, compound with (4aS-cis)-2,3,4,4a,9,9a-hexahydro-2,4a,9-trimethyl-1,2-oxazino[6,5-b]indol-6-yl methylcarbamate (1:1)
5-oxo-L-proline, compound with (4aS-cis)-2,3,4,4a,9,9a-hexahydro-2,4a,9-trimethyl-1,2-oxazino[6,5-b]indol-6-yl methylcarbamate (1:1)
Tricyclo[3.3.1.13,7]decane-1-carboxylicacid,(4aS,6R,8aS)-4a,5,9,10,11,12-hexahydro-6-hydroxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-3-ylester, hydrochloride (1:1)
1H-Pyrano[3,4-d]oxepin-4-carboxylicacid, 4a,5,6,8,9,9a-hexahydro-1-hydroxy-9-[2-(4-hydroxyphenyl)ethoxy]-6-oxo-,2-(3,4-dihydroxyphenyl)ethyl ester, (1R,4aS,9S,9aS)-rel-(+)-
(4aS,9aS)-5-amino-8-[(2-methoxy-5-methylphenyl)amino]-6-(trihydroxy-lambda~4~-sulfanyl)-4a,9a-dihydroanthracene-9,10-dione
1H-?4,?6,?9a-?(Epoxymetheno)?-?2-?oxacycloocta[cd]?pentalen-?1-?one, 2a,?3,?4α,?4a,?5,?7,?8,?9,?10β,?10β-?decahydro-?2aα,?3β,?4a,?9β-?tetrahydroxy-?5α,?9-?dimethyl-?, 9-?acetate 3-?methanesulfonate (8CI)